Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMMB | BMY | AMGN | GILD | REGN |
| Company | Chemomab Therapeutics Ltd ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7350 | 43.56 | 309.53 | 65.18 | 959.59 |
| High | 0.8500 | 44.81 | 314.60 | 65.22 | 969.98 |
| Low | 0.6921 | 43.49 | 306.32 | 64.52 | 956.76 |
| Last | 0.8100 | 44.74 | 312.86 | 64.58 | 968.00 |
| Change | +0.0850 | +1.07 | +5.55 | -0.34 | +12.24 |
| % Change | +11.72% | +2.45% | +1.81% | -0.52% | +1.28% |
| Volume | 124,800 | 10,776,300 | 2,921,300 | 6,048,500 | 281,900 |
| 20-Day Average Volume | 129,330 | 14,356,360 | 2,907,275 | 7,462,300 | 507,455 |
| Previous Close | 0.7250 | 43.67 | 307.31 | 64.92 | 955.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7143 | 46.17 | 279.47 | 66.10 | 915.54 |
| 20-Day Raw Stochastic | 59.08% | 22.60% | 84.27% | 5.83% | 96.01% |
| 20-Day Relative Strength | 55.42% | 35.71% | 68.03% | 31.74% | 60.06% |
| Weighted Alpha | -24.08 | -34.69 | +35.65 | -21.62 | +30.41 |
| Today's Opinion | 40% Buy | 100% Sell | 56% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 8% Buy | 100% Sell | 56% Buy | 100% Sell | 72% Buy |
| Last Month's Opinion | 40% Buy | 48% Sell | 40% Sell | 100% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.17% since 05/02/24 | +2.38% since 05/02/24 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | +3.24% since 05/02/24 |
| Low | 0.6030 on 05/08/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 926.94 on 05/03/24 |
| High | 0.9700 on 05/07/24 | 44.81 on 05/09/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 971.86 on 05/08/24 |
| 1-Month | |||||
| %Chg | +2.53% since 04/09/24 | -13.29% since 04/09/24 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +2.55% since 04/09/24 |
| Low | 0.5790 on 04/17/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 875.22 on 04/26/24 |
| High | 0.9700 on 05/07/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 971.86 on 05/08/24 |
| 3-Month | |||||
| %Chg | +35.00% since 02/09/24 | -10.18% since 02/09/24 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | +1.53% since 02/09/24 |
| Low | 0.5510 on 02/20/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 875.22 on 04/26/24 |
| High | 0.9700 on 05/07/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +35.00% since 11/09/23 | -11.25% since 11/09/23 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +20.96% since 11/09/23 |
| Low | 0.4200 on 12/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 783.57 on 11/10/23 |
| High | 1.0800 on 11/15/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,951 | 90,692,464 | 167,829,040 | 80,407,072 | 106,249,616 |
| Shares Outstanding, K | 11,050 | 2,027,100 | 536,435 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -24,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 3,145,000,000 |
| Last Quarter Net Income | -3,420,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 722,000,000 |
| 60-Month Beta | 0.39 | 0.45 | 0.60 | 0.22 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 03/07/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.59 | 16.50 | 16.11 | 25.75 |